BioSpace News Archive

Nanomerics Ltd., a world leader in molecular engineered delivery technologies, announced the Company had been granted patent protection in multiple territories for the use of its Molecular Envelope Technology for ocular applications.

An ureteroscope is an endoscope designed to work and view within the ureter. Other opportunities frequently used by endourologists and urologists is in incorporating the nephroscope and cystoscope.

Libtayo recommended for approval in the first-line treatment of certain patients with advanced non-small cell lung cancer whose tumors have ≥50% PD-L1 expression

The global patient handling equipment market has been anticipated in a report by Transparency Market Research to bear a highly competitive landscape for the next few years.

Healthcare analytics encompasses various technologies, methods, and skills employed at synthesizing and analyzing healthcare data from across a wide spectrum of health industries, with an aim to unravel crucial patterns and gain insights for improving healthcare outcomes.

Rise in demand for topical products due to their easy availability will enable growth in the porokeratosis treatment market

Abivax SA, a clinical-stage biotechnology company developing novel therapies that modulate the immune system to treat chronic inflammatory diseases, viral infections, and cancer, announces the suspension of the trading of its shares until the publication of the results of its phase 2b study for the treatment of ulcerative colitis with ABX464.

Zhaoke Ophthalmology Limited, an ophthalmic pharmaceutical company dedicated to the research, development and commercialization of therapies that address significant unmet medical needs, announced that on 13 May 2021, two pharmaceutical products of the Company, namely Bimatoprost Timolol eye drop and Epinastine HCl eye drop, passed the on-site inspection for drug registration of the Greater Bay Area Center for Drug Evaluation of NMPA.

Shanghai Stock Exchange listed company HitGen Inc. announced that it has entered into a research collaboration agreement with Dorian Therapeutics, Inc., a private biotechnology company developing senoblockers, a new class of therapeutics that can rejuvenate cells and tissues.

Itamar Medical Ltd., a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, announced the appointment of Brad Fluegel to its Board of Directors.